Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyramine oxidase (TynA) is a copper-containing enzyme primarily characterized in bacteria such as Escherichia coli, where it facilitates the oxidative deamination of primary amines like tyramine and phenylethylamine [UniProt P0AEC8, PMID: 1353444]. This enzymatic reaction produces the corresponding aldehyde, ammonia, and hydrogen peroxide, enabling the bacterium to utilize amines as a nitrogen source [PMID: 9461325]. TynA belongs to the family of copper-containing amine oxidases (CuAOs) and utilizes a unique, protein-derived cofactor known as topaquinone (TPQ), which is formed by the post-translational modification of a specific tyrosine residue [PMID: 10521336]. While TynA itself is not a common target for human clinical therapeutics, it is extensively studied as a structural and functional model for human CuAOs, including vascular adhesion protein-1 (VAP-1/AOC3) and diamine oxidase (DAO/AOC1) [PMID: 11932214]. Inhibitors of TynA, such as various hydrazine derivatives and semicarbazide, are used in research to explore the mechanisms of amine oxidation and to develop selective inhibitors that could potentially target related enzymes involved in human inflammatory and metabolic diseases [ChEMBL CHEMBL2595, PMID: 1353444].
Covalent inhibition of the topaquinone (TPQ) cofactor
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyramine oxidase (tynA) (tynA).